Is OCGN or OKUR more undervalued in 2026?

CirclFi compares Ocugen, Inc. (OCGN) and OnKure Therapeutics, Inc. (OKUR) using 13 institutional-grade valuation models. OCGN has a Quality of Company score of 6.6/10 while OKUR scores 5.6/10.

Which is a better buy — OCGN or OKUR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OCGN and OKUR valuations compare?

OCGN at $1.41 and OKUR at $4.12 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OCGN vs OKUR Valuation Comparison 2026 — Intrinsic Value Analysis

OCGN

Biotechnology

Ocugen, Inc.

Quality

6.6

out of 10

Value Trap

LOW

Price

$1.41

Last close

Models

8/13

Active

OKUR

Biotechnology

OnKure Therapeutics, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$4.12

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	OCGN Fair Value	OCGN Upside	OKUR Fair Value	OKUR Upside
Bayesian DCF	Intrinsic	$0.40	-71.8%	$3.04	-26.2%
Earnings Power Value	Intrinsic	—	—	$7.86	+66.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.22	-84.3%	$6.37	+54.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OCGN vs OKUR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OCGN vs OKUR — Which Stock Is More Undervalued?

OCGN scores higher with a 6.6/10 quality rating vs OKUR's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ocugen, Inc. (OCGN) and OnKure Therapeutics, Inc. (OKUR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OCGN currently trades at $1.41 with a QOC of 6.6/10, while OKUR trades at $4.12 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).